OCT 17, 2026 · JOURNAL ARTICLE
Metabolically unhealthy obesity is a novel risk factor for cisplatin- associated nephrotoxicity in patients with bladder cancer: a retrospective cohort study
BMC Urology
Abstract Purpose Cisplatin-associated nephrotoxicity limits chemotherapy in bladder cancer patients. Obesity defined by body mass index (BMI) has yielded conflicting findings regar